Felcisetrag
Term · Oncology and biomedicine · MLC-T-ONC-013549
A serotonin (5-HT) type 4 receptor agonist with potential gastrointestinal (GI) prokinetic activity. Upon administration, felcisetrag targets and binds to 5-HT4, thereby enhancing its activity. This may enhance GI motility, decrease GI tract and colonic transit time and improve constipation.
| Identifier | MLC-T-ONC-013549 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 5-HT4 agonist TAK-954; serotonin agonist TAK-954; serotonin 4 receptor agonist TAK-954 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013549",
"term": "Felcisetrag",
"field": "Oncology and biomedicine",
"definition": "A serotonin (5-HT) type 4 receptor agonist with potential gastrointestinal (GI) prokinetic activity. Upon administration, felcisetrag targets and binds to 5-HT4, thereby enhancing its activity. This may enhance GI motility, decrease GI tract and colonic transit time and improve constipation.",
"synonyms": [
"5-HT4 agonist TAK-954",
"serotonin agonist TAK-954",
"serotonin 4 receptor agonist TAK-954"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/felcisetrag/"
}
Record 7,197 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.